Kolon

fired layoffs cut executives dismissed
Biotech

Kolon TissueGene shrinks workforce after pivotal trial miss

Following a ph. 3 knee failure that its CEO acknowledged caused “great disappointment and concern,” TissueGene is laying off 37 Maryland employees.
Darren Incorvaia Aug 18, 2026 4:00pm
Knee arthritis osteoarthritis

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Jul 20, 2026 9:25am